Among patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
@jamasurgery.com
@jamasurgery.comAmong patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
@sigtrans-sttt.bsky.socialENO1 connects #Glycolysis with #GastricCancer stemness by regulating ATP pools and lactate homeostasis, which coordinate AMPK/mTOR and PI3K/AKT signaling to promote EMT, self-renewal, migration, and invasion.
@jamasurgery.comAmong patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
@biotechstockdaily.bsky.socialFirst patient enrolled in COMPASSION-37, Akeso's global Phase 3 of cadonilimab in first-line HER2-negative gastric cancer. Comparator: chemotherapy with or without nivolumab.
#GastricCancer #Biotech #Oncology
Disclaimer: This is NOT a financial advice
@doublewhammied.bsky.socialGuilford breaks down clinical management of hereditary diffuse #gastriccancer which is intense. Patients often have their stomachs removed, which comes w/ many adverse effects (& a few bennies, he noted, tongue firmly in cheek). #ILCSymposium #HDGC #lobmob #bcsm
@doublewhammied.bsky.socialKeynote speaker Dr. Parry Guilford breaks down the similarities between #lobular #breastcancer and diffuse #gastriccancer via a hereditary #CDH1 mutation. #ILCSymposium. Good to know as we enter Hereditary Cancer Awareness Week! #bcsm @lobularbca.bsky.social
@genesndiseases.bsky.socialMitochondrial redox balance could reveal new cancer clues.
This pan-cancer study links SLC25A39 to tumor progression, immune checkpoints and #immunotherapy response, highlighting its #biomarker potential. #GastricCancer
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
@degruyterbrillimms.bsky.socialCould metal nanoparticles overcome the limitations holding back early #GastricCancer detection?
#MetalNanoparticles (MNPs) paired with imaging, biosensors, liquid biopsy and #AI could boost biomarker detection and diagnostic accuracy.
@newsen.bsky.socialFerronova's MAGMAP Trial Shows Promise for Gastric Cancer Treatment with Lymph Node Mapping #Australia #Kyoto #Ferronova #GastricCancer #MAGMAP
@meducationai.bsky.social#GastricCancer #HemOnc #BoardPrep Boards coming up? 1,500+ board-style hem/onc questions and AI study tools for fellows at Meducation AI. Free 7-day trial: meducationai.com
@monalisarout1701.bsky.socialGastric cancer advances outlined:
🔬 7.7% cancer deaths worldwide
🔬 69% cases in Asia, high incidence in minorities
🔬 5-year survival varies, 36.4% overall
🔬 HER2 and PD-L1 testing in metastatic cases
#GastricCancer #Oncology #Immunotherapy https://tnyp.me/mkzMBbpw/s
@gastroagi.bsky.socialCould perioperative immunotherapy finally change the standard in resectable gastric cancer?
MATTERHORN showed that adding durvalumab to FLOT improved overall survival, with benefit extending across pCR, EFS and OS.
@northwell-journals.bsky.socialMolecular Medicine - Journal
Article in Press: HEATR1 deficiency enhanced gastric cancer cell PANoptosis to boost anti-tumor immunity | #MolecularMedicine #GastricCancer #PANoptosis #HEATR1 #ImmuneCheckpointInhibitor link.springer.com/article/10.1...
@vcclibrary.bsky.socialPD-L1 expression and survival in unresectable/recurrent #GastricCancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1. www.nature.com/articles/s41...
@mapjournals.bsky.social#GIT
WGCNA and machine learning identify CDRT15P1 as candidate hub gene in gastric adenocarcinoma; knockdown affects proliferation, migration, and invasion, implicating proteasome pathways.
Details: https://www.maxapress.com/article/doi/10.48130/git-0026-0011
#GastricCancer #HubGenes #CDRT15P1